Perry, 54, was found by his live-in assistant floating face down and lifeless in the hot tub of his Los Angeles home in October 2023. An autopsy concluded Perry died from the acute effects of ketamine ...
LOS ANGELES, Dec 3 (Reuters) - Ketamine, the powerful sedative that caused actor Matthew Perry's 2023 drug overdose death, ...
Nitrous oxide may offer quick, short-term relief for people with major depression, especially those who haven’t responded to ...
NRx has applied to FDA for use of KETAFREE™ as a proprietary product name, which is subject to review. KETAFREE™ is the first preservative-free ketamine formulation that does not include potentially ...
Nitrous oxide may ease depression within hours, according to trials. Learn how long effects last, safety findings, and ...
Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit ...
Developing NRX-101, an FDA-Designated Investigational Breakthrough Therapy for Suicidal Treatment-Resistant Bipolar Depression and Chronic Pain. - Designed to Help Address the Needs of Over 13 Million ...
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Helping those who others can’t is Dr. Tomer Levin’s specialty. Now he is expanding his Great Neck practice to Mineola so he ...
NRx has refiled its Abbreviated New Drug Application for KETAFREE™ (preservative free ketamine), received supportive correspondence from FDA, and expects Q2 2026 GDUFA date.HOPE Therapeutics is now ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company focused on unlocking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback